The multidisciplinary scientific program will be of interest to medicinal chemists, biologists and clinicians involved in drug research and development. The main therapeutic areas will be covered by the XXVI NMMC and NPCF12, among them oncology, immune-oncology, infectious diseases, neurodegenerative diseases, cardiovascular diseases, inflammation, metabolic diseases, rare and neglected diseases. In the frame of these general areas of interest, the scientific sessions will include plenary lectures and key notes, oral/flash and poster presentations, focusing on the following main topics:

  • First disclosure
  • New mechanisms, ¬†targets and proof of concept studies.
  • Repurposing
  • New modalities in drug discovery
  • Omics applied to the identification of biomarkers, target identification and validation
  • Nutraceuticals and Nutragenomics
  • Drug Design &¬†Structural biology
  • Biophysics and analytics in drug discovery
  • New synthetic strategies in medicinal chemistry
  • Cheminformatics
  • Biological Drugs